Revenue for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current revenue (TTM) is $309.06B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$309.06B
YoY change
+6.4%
5Y CAGR
+19.5%
Peak year (2025)
$309.06B
Cumulative revenue
$2.71T
Revenue history chart for Novo Nordisk (NVO) from 1985 to 2025
Revenue history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $309.06B | +6.4% | ||
| 2024 | $290.40B | +25.0% | ||
| 2023 | $232.26B | +31.3% | ||
| 2022 | $176.95B | +25.7% | ||
| 2021 | $140.80B | +10.9% | ||
| 2020 | $126.95B | +4.0% | ||
| 2019 | $122.02B | +9.1% | ||
| 2018 | $111.83B | +0.1% | ||
| 2017 | $111.70B | -0.1% | ||
| 2016 | $111.78B | +3.6% | ||
| 2015 | $107.93B | +21.5% | ||
| 2014 | $88.81B | +6.3% | ||
| 2013 | $83.57B | +7.1% | ||
| 2012 | $78.03B | +17.6% | ||
| 2011 | $66.35B | +9.2% | ||
| 2010 | $60.78B | +19.0% | ||
| 2009 | $51.08B | +11.9% | ||
| 2008 | $45.67B | +9.0% | ||
| 2007 | $41.89B | +8.1% | ||
| 2006 | $38.75B | +14.9% | ||
| 2005 | $33.71B | +15.3% | ||
| 2004 | $29.23B | +9.8% | ||
| 2003 | $26.61B | +5.8% | ||
| 2002 | $25.15B | +6.1% | ||
| 2001 | $23.72B | +13.9% | ||
| 2000 | $20.82B | +26.6% | ||
| 1999 | $16.44B | +20.5% | ||
| 1998 | $13.65B | -19.6% | ||
| 1997 | $16.98B | +14.0% | ||
| 1996 | $14.90B | +8.7% | ||
| 1995 | $13.71B | +1.4% | ||
| 1994 | $13.52B | +2.8% | ||
| 1993 | $13.15B | +23.2% | ||
| 1992 | $10.67B | +8.6% | ||
| 1991 | $9.83B | +18.0% | ||
| 1990 | $8.33B | +9.4% | ||
| 1989 | $7.62B | +35.3% | ||
| 1988 | $5.63B | +12.0% | ||
| 1987 | $5.03B | +20.1% | ||
| 1986 | $4.19B | +0.7% | ||
| 1985 | $4.16B | — |
Revenue values are taken from Novo Nordisk's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
2025's annual revenue for Novo Nordisk (NVO) came in at $309.06B – grew 6.4% year-over-year.
Novo Nordisk revenue compound annual growth for the 2020–2025 (5 years) window is +19.5%, sustaining 8 straight years of year-over-year growth.
The highest annual revenue of $309.06B was reported in 2025. The lowest in the available history was $4.16B in 1985.
Among 8 Healthcare peers, Novo Nordisk (NVO) ranks 2nd; the peer median for revenue is $63.09B.
Novo Nordisk Revenue by Year
Novo Nordisk Revenue 2025: $309.06B
Novo Nordisk revenue in 2025 was $309.06B, grew 6.4% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Revenue 2024: $290.40B
Novo Nordisk revenue in 2024 was $290.40B, grew 25.0% from 2023.
Novo Nordisk Revenue 2023: $232.26B
Novo Nordisk revenue in 2023 was $232.26B, surged 31.3% from 2022.
Novo Nordisk Revenue 2022: $176.95B
Novo Nordisk revenue in 2022 was $176.95B, grew 25.7% from 2021.
Novo Nordisk Revenue 2021: $140.80B
Novo Nordisk revenue in 2021 was $140.80B.
See more financial history for Novo Nordisk (NVO).
Sector peers — Revenue
Companies in the same sector as Novo Nordisk, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $44.56B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Novo Nordisk's revenue?
- Latest reported revenue for Novo Nordisk (NVO) is $309.06B (period ending December 31, 2025).
How has Novo Nordisk revenue changed year-over-year?
- Novo Nordisk (NVO) revenue changed +6.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk revenue?
- Novo Nordisk (NVO) revenue compound annual growth rate is +19.5% over the most recent 5 years available.
When did Novo Nordisk revenue hit its highest annual value?
- Novo Nordisk revenue reached its highest annual value of $309.06B in 2025.
What was Novo Nordisk revenue in 2024?
- Novo Nordisk (NVO) revenue in 2024 was $290.40B.
What was Novo Nordisk revenue in 2025?
- Novo Nordisk (NVO) revenue in 2025 was $309.06B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.